Biosynth Carbosynth and Shengquan Acquire New Plant to Increase Production Capacities in China

(Staad, Switzerland - November, 9th 2021) Biosynth Carbosynth, a leading life sciences reagents and custom synthesis and manufacturing services company, and JINAN SHENGQUAN GROUP SHARE-HOLDING CO., LTD. announced their acquisition of Kexing Biopharmaceutical Co., Ltd’s raw material factory in Jinan, China. With this acquisition, Biosynth Carbosynth’s and Shengquan’s joint venture Carbotang expands the production capacities significantly. The more than 30,000 square meter property contains a comprehensive factory building on 5 floors, a demo workshop and a large warehouse including a state-of-the-art dangerous material storage. The expansion through a further production site now allows the group more flexibility and larger production volumes together with an increased production reliability. This is an essential prerequisite in the production of Biosynth Carbosynth’s products.
 
Dr. Urs Spitz, CEO of Biosynth Carbosynth said “We are delighted to be further expanding our manufacturing operations and hugely successful joint venture. With this strategic acquisition we can continue to deliver our enormous range of products at increasing scales, with unrivalled expertise in complex organic chemistries.”
 
About Biosynth Carbosynth
Biosynth Carbosynth is a fully hybrid Research Products, Life Sciences Reagents and Custom Synthesis and Manufacturing Services Company with global research, manufacturing and distribution facilities. They are the supplier of choice for many in the pharmaceutical, life science, food, agrochemical, cosmetic and diagnostic sectors and manufacture and source a vast range of chemical and biochemical products. The company specializes in carbohydrates, nucleosides, phospholipids, enzyme substrates, antimicrobials, APIs and natural products and has a full range of reagents for protein production and analysis. Find out more about Biosynth Carbosynth at  www.biosynth-carbosynth.com.
 
About Carbotang
Carbotang was established in 2010 as a joint venture between Shengquan based in Jinan, China and Carbosynth in Compton, UK. The JV brought together the capabilities to extract rare sugars from natural resources such as corn cobs and the know-how to manufacture downstream products such as pharmaceutical precursors, cosmetic ingredients and applications in nutraceuticals.